id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2009-Q-0301-0032,FDA,FDA-2009-Q-0301,"FDA/CFSAN Office of Nutrition, Labeling, and Dietary Supplements to the Division of Dockets Management, June 27, 2011 - Letter",Other,Letter(s),2011-08-17T04:00:00Z,2011,8,2011-08-17T04:00:00Z,,2011-08-17T17:39:26Z,,0,0,0900006480eb5f41
FDA-2009-Q-0301-0027,FDA,FDA-2009-Q-0301,"FDA/CDER, Division of Pulmonary, Allergy and Rheumatology Products (DPARP) Medical Officer Consultation, April 11, 2011 - [Nestle Infant Nutrition/Gerber Products Company - Qualified Health Claim Petition] - Background Material",Supporting & Related Material,BKG-Background Material,2011-06-09T04:00:00Z,2011,6,,,2011-06-09T22:46:51Z,,0,0,0900006480e33fe2
FDA-2009-Q-0301-0024,FDA,FDA-2009-Q-0301,"Consultation Between CDER DPARP and CFSAN on ""Most Common Disease...."", March 15, 2011 - [Nestle Infant Nutrition/Gerber Products Company - Qualified Health Claim Petition] - Background Material",Supporting & Related Material,CP-Citizen Petition (Supporting & Related Materials),2011-06-09T04:00:00Z,2011,6,,,2011-06-09T22:46:44Z,,0,0,0900006480e33f1e
FDA-2009-Q-0301-0023,FDA,FDA-2009-Q-0301,"FDA/CDER Division of Dermatology and Dental Drug Products (DDDP), Medical Officer, Dermatology, Memorandum, April 21, 2010 - [Nestle Infant Nutrition/Gerber Products Company - Qualified Health Claim Petition] - Background Material",Supporting & Related Material,CP-Citizen Petition (Supporting & Related Materials),2011-06-09T04:00:00Z,2011,6,,,2011-06-09T22:46:42Z,,0,0,0900006480e33f1c
FDA-2009-Q-0301-0022,FDA,FDA-2009-Q-0301,"FDA/CDER, Division of Pulmonary, Allergy and Rheumatology Products (DPARP) Medical Officer Consultation Final, April 5, 2010 - [Nestle Infant Nutrition/Gerber Products Company - Qualified Health Claim Petition] - Background Material",Supporting & Related Material,CP-Citizen Petition (Supporting & Related Materials),2011-06-09T04:00:00Z,2011,6,,,2011-06-09T22:46:40Z,,0,0,0900006480e33f1a
FDA-2009-Q-0301-0025,FDA,FDA-2009-Q-0301,"FDA/CDER, Division of Pulmonary, Allergy and Rheumatology Products (DPARP) Medical Officer Consultation, March 14, 2010 - [Nestle Infant Nutrition/Gerber Products Company - Qualified Health Claim Petition] - Background Material",Supporting & Related Material,CP-Citizen Petition (Supporting & Related Materials),2011-06-09T04:00:00Z,2011,6,,,2011-06-09T22:46:46Z,,0,0,0900006480e33fde
FDA-2009-Q-0301-0028,FDA,FDA-2009-Q-0301,"FDA/CFSAN to the Division of Dockets Management re: Qualified Health Claim for 100% Whey-Protein Hydrolyzed Infant Formula and a Reduced Risk of Atopic Dermatitis, May 27 and May 25, 2011 - Letter",Other,LET-Letter,2011-06-09T04:00:00Z,2011,6,2011-06-09T04:00:00Z,,2013-07-27T23:55:27Z,,0,0,0900006480e439dd
FDA-2009-Q-0301-0029,FDA,FDA-2009-Q-0301,"Enclosure 1 - ""Abbott Laboratories Comment to FDA/CFSAN/ONLDS"" - [FDA/CFSAN to the Division of Dockets Management re: Qualified Health Claim for 100% Whey-Protein Hydrolyzed Infant Formula and a Reduced Risk of Atopic Dermatitis, May 27 and May 25, 2011 - Letter] re FDA-2009-Q-0301-0028",Supporting & Related Material,LET-Letter (Supporting and Related Material),2011-06-09T04:00:00Z,2011,6,,,2011-06-09T23:14:57Z,,0,0,0900006480e373e2
FDA-2009-Q-0301-0026,FDA,FDA-2009-Q-0301,"Comment on Typographical Emphasis on an Infant Formula QHC, April 12, 2011 - [Nestle Infant Nutrition/Gerber Products Company - Qualified Health Claim Petition] - Background Material",Supporting & Related Material,BKG-Background Material,2011-06-09T04:00:00Z,2011,6,,,2011-06-09T22:46:49Z,,0,0,0900006480e33fe0
FDA-2009-Q-0301-0031,FDA,FDA-2009-Q-0301,"Enclosure 3 - ""Toit, et al., Can Food Allergy be Prevented? The Current Evidence"" - [FDA/CFSAN to the Division of Dockets Management re: Qualified Health Claim for 100% Whey-Protein Hydrolyzed Infant Formula and a Reduced Risk of Atopic Dermatitis, May 27 and May 25, 2011 - Letter] re FDA-2009-Q-0301-0028",Supporting & Related Material,,2011-06-09T00:00:00Z,2011,6,,,2011-06-09T23:17:27Z,,0,1,0900006480e373e4
FDA-2009-Q-0301-0030,FDA,FDA-2009-Q-0301,"Enclosure 2 - ""ASCIA Annual Scienific Meeting 2008 Abstracts"" - [FDA/CFSAN to the Division of Dockets Management re: Qualified Health Claim for 100% Whey-Protein Hydrolyzed Infant Formula and a Reduced Risk of Atopic Dermatitis, May 27 and May 25, 2011 - Letter] re FDA-2009-Q-0301-0028",Supporting & Related Material,,2011-06-09T00:00:00Z,2011,6,,,2011-06-09T23:17:53Z,,0,1,0900006480e373e3
FDA-2009-Q-0301-0019,FDA,FDA-2009-Q-0301,"FDA/CFSAN to Regulatory Discretion, Inc - Letter",Supporting & Related Material,LET-Letter (Supporting and Related Material),2011-06-02T04:00:00Z,2011,6,,,2016-10-31T15:03:11Z,,0,0,0900006480e39a5c
FDA-2009-Q-0301-0020,FDA,FDA-2009-Q-0301,"FDA/CFSAN to the Division of Dockets Management re: Qualified Health Claim for 100% Whey-Protein Hydrolyzed Infant Formula and a Reduced Risk of Atopic Dermatitis, May 25, 2011 - Letter",Other,LET-Letter,2011-06-02T04:00:00Z,2011,6,2011-06-02T04:00:00Z,,2013-08-11T04:46:04Z,,0,0,0900006480e34a14
FDA-2009-Q-0301-0018,FDA,FDA-2009-Q-0301,"Nestle Infant Nutrition to FDA/CFSAN, April 7, 2011 - Letter",Other,LET-Letter,2011-05-18T04:00:00Z,2011,5,2011-05-18T04:00:00Z,,2011-06-02T22:04:01Z,,0,0,0900006480d1e55c
FDA-2009-Q-0301-0015,FDA,FDA-2009-Q-0301,"FDA/CFSAN Memorandum to the Division of Dockets Management, February 23, 2011 - Memorandum",Other,M-Memorandum,2011-03-04T05:00:00Z,2011,3,2011-03-04T05:00:00Z,,2013-08-11T03:13:23Z,,0,0,0900006480bfb3b3
FDA-2009-Q-0301-0017,FDA,FDA-2009-Q-0301,"Enclosure 1 - ""...100% Whey-Protein Partially Hydrolyzed Infant Formula and Reduced Rist of Atopc Dermatitis"" - [Nestle Infant Nutrition to FDA/CFSAN, November 8, 2010 - Letter] re FDA-2009-Q-0301-0016",Supporting & Related Material,LET-Letter (Supporting and Related Material),2011-03-04T05:00:00Z,2011,3,,,2011-03-05T00:13:07Z,,0,0,0900006480bfb3b5